High-dose chemotherapy with autologous stem cell support, treatment for chronic leukemia
Record ID 32005000033
English
Authors' objectives:
High-dose chemotherapy (HDC) involves use of anticancer drugs in concentrations much higher than conventional therapy, with the goal to eradicate cancer cells more effectively and thereby improve survival. Since HDC is highly toxic to the bone marrow, autologous bone marrow or peripheral blood stem cell transplantation is performed to enhance recovery of the hematopoietic system after completion of the chemotherapy.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2004
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=1941
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Drug Therapy
- Hematopoietic Stem Cell Transplantation
- Leukemia
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.